On the morning of April 26, 2022, Huang Donghong, Director of Hunan Provincial Drug Administration, and his delegation visited the company's Liuyang production base to conduct a special research on the production and operation of traditional Chinese medicine formula granules. Zeng Linggui, member of the Party Group and Deputy Director of the Provincial Bureau, Yang Qing, Director of the Drug Production Supervision and Administration Department, Wu Zhengfei from the Drug Registration Management and Technology Department, and Li Pengfei from the Comprehensive and Planning Finance Department accompanied the research. Cai Xinya, member of the Party Committee, Vice General Manager, and Chairman of Xingxiang Group, Shen Fanshun, General Manager, and members of the management team and department heads received the research team.

Provincial leaders listen to report on the construction of automatic control system in the extraction workshop of the new production line

Zeng Linggui, Deputy Director, and Yang Qing, Director, conducted research on the extraction workshop of the new production line

Director Huang Donghong and his delegation conducted on-site research on the company's new production line for extracting traditional Chinese medicine formula granules and the drug research institute, and had in-depth exchanges with company leaders to gain a detailed understanding of the company's research, production, and sales of traditional Chinese medicine formula granules standards.

At the symposium, Chairman Cai Xinya warmly welcomed Director Huang Donghong and his delegation for their guidance, and expressed sincere gratitude to the leaders of the provincial bureau for their concern and support for the company. Cai Xinya introduced the company's research and production sales of traditional Chinese medicine formula granules standards, the construction of a new production line for traditional Chinese medicine formula granules, product traceability system, traditional Chinese medicine resource business, new product research and development, digital transformation, and asset securitization. At the same time, he stated that the company will take advantage of Hunan becoming a national demonstration zone for comprehensive reform of traditional Chinese medicine, deepen standard research, control product quality, serve the people well, and further expand, strengthen, and optimize the traditional Chinese medicine industry.

Director Huang Donghong fully affirmed the efforts made by the company in the development of the traditional Chinese medicine formula granule industry. She pointed out that in the future, the provincial bureau will continue to support the company's development. On the premise of ensuring safety production, the company should seek more effective development models, ensure production capacity during the transition period, meet market demand, and jointly promote the development of the traditional Chinese medicine formula granule industry in our province. At the same time, she put forward four specific requirements: firstly, we must strictly adhere to the bottom line of drug quality and safety, resolutely implement the "four strictest", and ensure that products can be traced back to their sources, destinations, and responsibilities; Secondly, we must actively and strictly follow national policy requirements to accelerate the research and production progress of traditional Chinese medicine formula granules standards; Thirdly, as a pioneer in the production of traditional Chinese medicine formula granules in our province, Chunguang Jiuhui has experience, market, scale, and research and development capabilities. It should take on the important responsibility of inheriting and innovating traditional Chinese medicine culture, demonstrating the responsibility of state-owned enterprises; The fourth is to stand in an international perspective, give full play to the advantages of state-owned enterprises, and build the company into a demonstration benchmark for Hunan pharmaceutical enterprises, making new and greater contributions to the high-quality development of the traditional Chinese medicine industry in our province.